Abiopharma

🔍 SORRELLS JULIE MARIE (Executive)

Company: Amcor plc (AMCR)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 769 shares of Ordinary Shares (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,768.60 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 272 shares of Ordinary Shares (Direct)
  Date: 2026-08-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 8,496.60 | transaction_form_type: 4 | Footnotes: F4
• Acquired 1,047 shares of Ordinary Shares (Direct)
  Date: 2026-08-28 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,543.80 | transaction_form_type: 4 | Footnotes: F2
• Sold 350 shares of Ordinary Shares (Direct)
  Date: 2026-08-28 | Code: F | equity_swap_involved: 0 | shares_owned_after: 9,193.80 | transaction_form_type: 4 | Footnotes: F5
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: By 401(K) Plan | shares_owned_after: 1,534.80
• Acquired 1,090 shares of Employee Stock Options at $46.75 per share (Derivative)
  Date: 2026-08-26 | Code: A | Expires: 2033-09-15 | Exercise: 2026-08-28 | equity_swap_involved: 0 | shares_owned_after: 1,090.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 1,047 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-28 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F7, F7

Footnotes:

• F1: Settlement of performance shares that were granted on September 15, 2022 under the 2023-2024 Long Term Incentive plan of Amcor Limited ("Old Amcor"), a predecessor of Amcor, plc ("Amcor"). 769 of the 4,440 performance shares vested based on achievement of the performance conditions and the remaining performance shares were forfeited.
• F2: Each restricted stock unit represents a contingent right to receive one ordinary share of Amcor upon vesting of the restricted stock units.
• F3: Reflects the deduction of 143 shares from the reporting person's directly held shares to reflect the full number of shares withheld on August 28, 2025 (adjusted for the 1-for-5 reverse stock split that became effective on January 14, 2026) in the exempt share withholding transaction reported on the reporting person's Form 4 filed on September 2, 2025. The number of shares withheld was initially underreported due to an administrative error.
• F4: 272 shares withheld for tax withholding arising from the recent equity plan vesting resulting in 497 shares.
• F5: 350 shares withheld for tax withholding arising from the recent equity plan vesting resulting in 697.20 shares.
• F6: Vesting of Employee Stock Options that were granted on September 15, 2023 under Old Amcor's 2023-2024 Long Term Incentive Plan. 1,090 of the 6,300 Employee Stock Options vested and the remaining Employee Stock Options were forfeited. The Employee Stock Options remain subject to a share price condition whereby the share price must exceed the exercise price for the Employee Stock Options to be exercisable.
• F7: The restricted stock units were granted on September 16, 2024 and vest August 28, 2026.